These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
26. [Following 90 patients with antiphospholipid syndrome with antibody titers and correlations with clinical manifestations: symptoms of the disease, a new antibody and correlations with clinical manifestations in the Israeli population]. Marai I; Levi Y; Godard G; Shoenfeld Y Harefuah; 2001 Jun; 140(6):495-500, 565. PubMed ID: 11420848 [TBL] [Abstract][Full Text] [Related]
27. Is the determination of anti-beta2 glycoprotein I antibodies useful in patients with venous thromboembolism without the antiphospholipid syndrome? Hsieh K; Knöbl P; Rintelen C; Kyrle PA; Quehenberger P; Bialonczyk C; Partsch H; Lechner K; Pabinger I Br J Haematol; 2003 Nov; 123(3):490-5. PubMed ID: 14617012 [TBL] [Abstract][Full Text] [Related]
28. Lupus anticoagulant is significantly associated with inflammatory reactions in patients with suspected deep vein thrombosis. Sidelmann JJ; Sjøland JA; Gram J; Bertelsen V; Mourits-Andersen T; Münster H; Münster AM; Jespersen J Scand J Clin Lab Invest; 2007; 67(3):270-9. PubMed ID: 17454841 [TBL] [Abstract][Full Text] [Related]
30. Echocardiographic abnormalities and antiphospholipid antibodies in patients with systemic lupus erythematosus. Falcao CA; Alves IC; Chahade WH; Duarte AL; Lucena-Silva N Arq Bras Cardiol; 2002 Sep; 79(3):285-91. PubMed ID: 12386730 [TBL] [Abstract][Full Text] [Related]
31. Antiphospholipid and other autoantibodies in a cohort of habitual aborters and healthy multiparous women in Jamaica. Roye-Green K; Frederick J; Wharfe G; Choo-Kang E; DaCosta V; Fletcher H; Smikle M Hum Antibodies; 2011; 20(1-2):1-5. PubMed ID: 21558618 [TBL] [Abstract][Full Text] [Related]
32. IgG reactivity to phospholipid-bound beta(2)-glycoprotein I is the main determinant of the fraction of lupus anticoagulant activity quenched by addition of hexagonal (II) phase phospholipid in patients with the clinical suspicion of antiphospholipid-antibody syndrome. Safa O; Crippa L; Della Valle P; Sabbadini MG; Viganò D'Angelo S; D'Angelo A Haematologica; 1999 Sep; 84(9):829-38. PubMed ID: 10477458 [TBL] [Abstract][Full Text] [Related]
33. Clinical significance of antiphospholipid antibodies in Indian scleroderma patients. Gupta R; Thabah MM; Gupta S; Shankar S; Kumar A Rheumatol Int; 2009 Dec; 30(2):277-9. PubMed ID: 19701755 [TBL] [Abstract][Full Text] [Related]
34. Antiphospholipid antibodies and thrombosis in systemic lupus erythematosus: comparison of three lupus anticoagulant assays and anticardiolipin ELISA in 188 patients. Jouhikainen T; Julkunen H; Vaarala O; Leirisalo-Repo M; Stephansson E; Vahtera E; Palosuo T; Myllylä G Blood Coagul Fibrinolysis; 1992 Aug; 3(4):407-14. PubMed ID: 1420816 [TBL] [Abstract][Full Text] [Related]
35. The association of antiphospholipid antibodies with intrauterine fetal death: a case-control study. Helgadottir LB; Skjeldestad FE; Jacobsen AF; Sandset PM; Jacobsen EM Thromb Res; 2012 Jul; 130(1):32-7. PubMed ID: 22178574 [TBL] [Abstract][Full Text] [Related]
40. Antiphospholipid antibodies and risk of myocardial infarction and ischaemic stroke in young women in the RATIO study: a case-control study. Urbanus RT; Siegerink B; Roest M; Rosendaal FR; de Groot PG; Algra A Lancet Neurol; 2009 Nov; 8(11):998-1005. PubMed ID: 19783216 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]